Submitted by Anonymous (not verified) on 22 July 2024 - 11:15
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0114/2023
Source: